Perk Labs Inc
OTC:PKLBF
Balance Sheet
Balance Sheet Decomposition
Perk Labs Inc
Perk Labs Inc
Balance Sheet
Perk Labs Inc
| Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
10
|
6
|
2
|
1
|
1
|
0
|
|
| Cash |
0
|
0
|
10
|
6
|
2
|
1
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
11
|
8
|
4
|
1
|
2
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
1
|
4
|
1
|
0
|
1
|
0
|
|
| Total Assets |
1
N/A
|
1
+7%
|
13
+1 077%
|
12
-4%
|
5
-62%
|
2
-65%
|
3
+95%
|
0
-85%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+140%
|
1
+847%
|
1
-63%
|
0
-27%
|
1
+58%
|
0
-21%
|
0
-46%
|
|
| Equity | |||||||||
| Common Stock |
2
|
3
|
20
|
33
|
33
|
34
|
36
|
37
|
|
| Retained Earnings |
1
|
2
|
9
|
21
|
29
|
33
|
34
|
37
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
-1%
|
12
+1 112%
|
12
+3%
|
4
-64%
|
1
-76%
|
3
+158%
|
0
-92%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+7%
|
13
+1 077%
|
12
-4%
|
5
-62%
|
2
-65%
|
3
+95%
|
0
-85%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
56
|
58
|
127
|
137
|
137
|
152
|
182
|
203
|
|